Anti-viral Assessment of Phytoconstituents in a Traditional (Siddha Medicine) Polyherbal Formulation - Targeting Mpro and Pan-coronavirus Post-fusion Spike Protein

Overview

Journal J Tradit Complement Med

Specialty Rehabilitation Medicine

Date 2024 Jan 15

PMID 38223813

Authors

Sumit Kumar Mandal

Md Muzaffar-Ur Rehman

Ashish Katyal

Kanishk Rajvanshi

Manoj Kannan

Mohit Garg

Sankaranarayanan Murugesan

P R Deepa

Affiliations

Soon will be listed here.

Abstract

Background And Aim: Novel nature of the viral pathogen SARS-CoV-2 and the absence of standard drugs for treatment, have been a major challenge to combat this deadly infection. Natural products offer safe and effective remedy, for which traditional ethnic medicine can provide leads. An indigenous poly-herbal formulation, Kabasura Kudineer from Siddha system of medicine was evaluated here using a combination of computational approaches, to identify potential inhibitors against two anti-SARS-CoV-2 targets - post-fusion Spike protein (structural protein) and main protease (Mpro, non-structural protein).

Experimental Procedure: We docked 32 phytochemicals from the poly-herbal formulation against viral post-fusion Spike glycoprotein and Mpro followed by molecular dynamics using Schrodinger software. Drug-likeness analysis was performed using machine learning (ML) approach and pkCSM.

Results: The binding affinity of the phytochemicals in Kabasura Kudineer revealed the following top-five bioactives: Quercetin > Luteolin > Chrysoeriol > 5-Hydroxy-7,8-Dimethoxyflavone > Scutellarein against Mpro target, and Gallic acid > Piperlonguminine > Chrysoeriol > Elemol > Piperine against post-fusion Spike protein target. Quercetin and Gallic acid exhibited binding stability in complexation with their respective viral-targets and favourable free energy change as revealed by the molecular dynamics simulations and MM-PBSA analysis. predicted pharmacokinetic profiling of these ligands revealed appropriate drug-likeness properties.

Conclusion: These outcomes provide: (a) potential mechanism for the anti-viral efficacy of the indigenous Siddha formulation, targeting Mpro and post-fusion Spike protein (b) top bioactive lead-molecules that may be developed as natural product-based anti-viral pharmacotherapy and their pleiotropic protective effects may be leveraged to manage co-morbidities associated with COVID-19.

Citing Articles

In silico molecular screening of bioactive natural compounds of rosemary essential oil and extracts for pharmacological potentials against rhinoviruses.

Singh D, Mittal N, Mittal P, Tiwari N, Khan S, Ali M Sci Rep. 2024; 14(1):17426.

PMID: 39075176 PMC: 11286848. DOI: 10.1038/s41598-024-68450-3.

In Silico Approaches to Polyherbal Synergy: Protocol for a Scoping Review.

Chandhiruthil Sathyan A, Yadav P, Gupta P, Mahapathra A, Galib R JMIR Res Protoc. 2024; 13:e56646.

PMID: 38857494 PMC: 11196908. DOI: 10.2196/56646.

The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection.

Wang Z, Yang L Nutrients. 2023; 15(15).

PMID: 37571380 PMC: 10421531. DOI: 10.3390/nu15153443.

References

Kumar B, Manandhar S, Mehta C, Nayak U, Pai K . Structure-based docking, pharmacokinetic evaluation, and molecular dynamics-guided evaluation of traditional formulation against SARS-CoV-2 spike protein receptor bind domain and ACE2 receptor complex. Chem Zvesti. 2021; 76(2):1063-1083. PMC: 8522134. DOI: 10.1007/s11696-021-01917-z. View

Huang H, Zhang G, Zhou Y, Lin C, Chen S, Lin Y . Reverse Screening Methods to Search for the Protein Targets of Chemopreventive Compounds. Front Chem. 2018; 6:138. PMC: 5954125. DOI: 10.3389/fchem.2018.00138. View

Ekberg V, Ryde U . On the Use of Interaction Entropy and Related Methods to Estimate Binding Entropies. J Chem Theory Comput. 2021; 17(8):5379-5391. PMC: 8389774. DOI: 10.1021/acs.jctc.1c00374. View

Shah B, Modi P, Trivedi P . Pharmacophore- based virtual screening, 3D- QSAR, molecular docking approach for identification of potential dipeptidyl peptidase IV inhibitors. J Biomol Struct Dyn. 2020; 39(6):2021-2043. DOI: 10.1080/07391102.2020.1750485. View

Wu H, Gong K, Qin Y, Yuan Z, Xia S, Zhang S . In silico analysis of the potential mechanism of a preventive Chinese medicine formula on coronavirus disease 2019. J Ethnopharmacol. 2021; 275:114098. PMC: 8020622. DOI: 10.1016/j.jep.2021.114098. View

Malik A, Phanus-Umporn C, Schaduangrat N, Shoombuatong W, Isarankura-Na-Ayudhya C, Nantasenamat C . HCVpred: A web server for predicting the bioactivity of hepatitis C virus NS5B inhibitors. J Comput Chem. 2020; 41(20):1820-1834. DOI: 10.1002/jcc.26223. View

Mandal S, Karan Kumar B, Sharma P, Murugesan S, Deepa P . In silico and in vitro analysis of PPAR - α / γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat. Comput Biol Med. 2022; 147:105796. DOI: 10.1016/j.compbiomed.2022.105796. View

Miller 3rd B, McGee Jr T, Swails J, Homeyer N, Gohlke H, Roitberg A . MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. J Chem Theory Comput. 2015; 8(9):3314-21. DOI: 10.1021/ct300418h. View

Xu J, Zhang Y . Traditional Chinese Medicine treatment of COVID-19. Complement Ther Clin Pract. 2020; 39:101165. PMC: 7118627. DOI: 10.1016/j.ctcp.2020.101165. View

10.

Di Petrillo A, Orru G, Fais A, Fantini M . Quercetin and its derivates as antiviral potentials: A comprehensive review. Phytother Res. 2021; 36(1):266-278. PMC: 8662201. DOI: 10.1002/ptr.7309. View

11.

Srivastava A, Rengaraju M, Srivastava S, Narayanan V, Gupta V, Upadhayay R . Efficacy of two siddha polyherbal decoctions, Nilavembu Kudineer and Kaba Sura Kudineer, along with standard allopathy treatment in the management of mild to moderate symptomatic COVID-19 patients-a double-blind, placebo-controlled, clinical trial. Trials. 2021; 22(1):570. PMC: 8397852. DOI: 10.1186/s13063-021-05478-0. View

12.

Jain J, Narayanan V, Chaturvedi S, Pai S, Sunil S . In Vivo Evaluation of Withania somnifera-Based Indian Traditional Formulation ( Amukkara Choornam), Against Chikungunya Virus-Induced Morbidity and Arthralgia. J Evid Based Integr Med. 2018; 23:2156587218757661. PMC: 5871050. DOI: 10.1177/2156587218757661. View

13.

Banks J, Beard H, Cao Y, Cho A, Damm W, Farid R . Integrated Modeling Program, Applied Chemical Theory (IMPACT). J Comput Chem. 2005; 26(16):1752-80. PMC: 2742605. DOI: 10.1002/jcc.20292. View

14.

Bellik Y, Hammoudi S, Abdellah F, Iguer-Ouada M, Boukraa L . Phytochemicals to prevent inflammation and allergy. Recent Pat Inflamm Allergy Drug Discov. 2012; 6(2):147-58. DOI: 10.2174/187221312800166886. View

15.

Nutt D, Smith J . Molecular Dynamics Simulations of Proteins: Can the Explicit Water Model Be Varied?. J Chem Theory Comput. 2015; 3(4):1550-60. DOI: 10.1021/ct700053u. View

16.

Cheng H, Zhang L, Liang Y, Hsu Y, Lee I, Liaw C . Antiinflammatory and Antioxidant Flavonoids and Phenols from Cardiospermum halicacabum ( Dào Dì Líng). J Tradit Complement Med. 2014; 3(1):33-40. PMC: 3924979. DOI: 10.4103/2225-4110.106541. View

17.

Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S . Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020; 30(4):343-355. PMC: 7104723. DOI: 10.1038/s41422-020-0305-x. View

18.

Singh R, Bhardwaj V, Sharma J, Purohit R, Kumar S . In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors. J Tradit Complement Med. 2021; 12(1):35-43. PMC: 8172245. DOI: 10.1016/j.jtcme.2021.05.005. View

19.

Valdes-Tresanco M, Valdes-Tresanco M, Valiente P, Moreno E . gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS. J Chem Theory Comput. 2021; 17(10):6281-6291. DOI: 10.1021/acs.jctc.1c00645. View

20.

Shirts M, Klein C, Swails J, Yin J, Gilson M, Mobley D . Lessons learned from comparing molecular dynamics engines on the SAMPL5 dataset. J Comput Aided Mol Des. 2016; 31(1):147-161. PMC: 5581938. DOI: 10.1007/s10822-016-9977-1. View